GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,650.50
Bid: 1,652.00
Ask: 1,652.50
Change: 35.50 (2.20%)
Spread: 0.50 (0.03%)
Open: 1,631.00
High: 1,663.50
Low: 1,630.50
Prev. Close: 1,615.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: FTSE bounces off five-month low after late rally

Tue, 16th Jun 2015 17:08

UK stocks managed to claw their way back to finish flat on Tuesday as investors sought out bargains after markets dropped to a five-month intraday low.Stocks in the tobacco, housebuilding and pharmaceutical sectors extended gains late on, while Royal Mail rebounded after earlier weakness, making up for falls in the heavyweight mining and banking sectors.The FTSE 100 ended the day down just 0.42 points (-0.01%) at 6,710.10 after a late afternoon rally across Europe.The rebound followed a decent start on Wall Street after stronger-than-expected housing data, with May US housing permits rising at their fastest rate since 2007.Nevertheless, the Footsie sank to a daily low of 6,656.90 earlier on, a level not seen mid-January, as the Greek debt crisis raged on.An abrupt end to negotiations at the weekend in Brussels with Greece's lenders has rattled investors' nerves over recent days, as discussions collapsed after just 45 minutes on the back of disagreements over issues such as pension reforms and tax rates.Eurozone officials are now considering an emergency summit next weekend amid fears that Athens and its creditors will not reach a deal at a meeting of finance ministers on Thursday."While this does cue up excitement for the end of this week and the beginning of the next, it leaves us no further along the road to a solution," said IG analyst Chris Beauchamp.Defensives gainA reduction in risk appetite benefitted stocks in defensive sectors such as tobacco and pharmaceuticals. British American Tobacco, Imperial Tobacco and Glaxosmithkline all finished higher and managed to hold on to gains despite the wider market rally.British American Tobacco and Imperial Tobacco were boosted after Credit Suisse reinstated coverage on both stocks at 'outperform'. The broker applauded BAT's "consistent track record" and showed optimism about Imperial's recent purchase of Reynolds assets.Meanwhile, GSK was up on rumours it could become the latest takeover target in the industry. According to the Daily Mail, market participants are speculating that the company may face an approach from Switzerland's Roche or US company Johnson & Johnson at about 1900p per share.Housebuilders also performed well, such as Barratt Developments, Taylor Wimpey, Persimmon and Crest Nicholson. Crest Nicholson impressed with an upbeat outlook as it posted a 52% jump in first-half profits.Royal Mail shares bounced into positive territory, erasing earlier losses on concerns about an Ofcom review into the regulation of the postal operator after the withdrawal of rival Whistl. Despite investor concerns, Investec reiterated a 'buy' recommendation on Royal Mail, saying: "We do not expect any substantive changes when the review concludes in 2016."Industrial equipment hire company Ashtead underwhelmed with full-year results. The group posted a 33% rise in full-year pre-tax profit to £473.8m on strong US and UK markets.Market MoverstechMARK 3,153.62 +0.07%FTSE 100 6,710.10 -0.01%FTSE 250 17,736.19 +0.04%FTSE 100 - RisersBritish American Tobacco (BATS) 3,511.00p +2.92%Barratt Developments (BDEV) 609.50p +2.27%Imperial Tobacco Group (IMT) 3,246.00p +2.24%Centrica (CNA) 267.40p +2.06%Taylor Wimpey (TW.) 186.90p +1.91%Persimmon (PSN) 1,959.00p +1.66%Mondi (MNDI) 1,380.00p +1.32%SABMiller (SAB) 3,336.50p +1.12%GlaxoSmithKline (GSK) 1,366.00p +1.11%National Grid (NG.) 858.00p +1.11%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 4,502.00p -2.68%Ashtead Group (AHT) 1,097.00p -2.66%Anglo American (AAL) 972.20p -2.23%Rio Tinto (RIO) 2,745.50p -2.17%Antofagasta (ANTO) 712.50p -2.13%Fresnillo (FRES) 720.00p -1.84%BT Group (BT.A) 445.25p -1.61%Glencore (GLEN) 274.20p -1.46%International Consolidated Airlines Group SA (CDI) (IAG) 502.00p -1.28%ARM Holdings (ARM) 1,089.00p -1.27%FTSE 250 - RisersLadbrokes (LAD) 122.10p +4.36%De La Rue (DLAR) 535.50p +2.78%Man Group (EMG) 164.80p +2.36%Petra Diamonds Ltd.(DI) (PDL) 159.00p +2.32%Fidessa Group (FDSA) 2,255.00p +2.27%Crest Nicholson Holdings (CRST) 556.00p +2.11%Ted Baker (TED) 2,906.00p +2.07%Atkins (WS) (ATK) 1,532.00p +1.79%Computacenter (CCC) 730.00p +1.74%National Express Group (NEX) 313.50p +1.69%FTSE 250 - FallersKaz Minerals (KAZ) 232.00p -4.92%Centamin (DI) (CEY) 61.65p -3.52%Allied Minds (ALM) 545.00p -2.94%Lonmin (LMI) 127.00p -2.08%Tullow Oil (TLW) 362.00p -2.00%Petrofac Ltd. (PFC) 882.50p -2.00%Vedanta Resources (VED) 582.00p -1.94%Cairn Energy (CNE) 181.10p -1.90%Wood Group (John) (WG.) 674.00p -1.89%Rathbone Brothers (RAT) 2,178.00p -1.80%
More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.